Press release
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia - Drug Pipeline Landscape
Fibromyalgia can be diagnosed if the patient had widespread pain for 3 months or longer. Healthcare professionals use a process of elimination to diagnose fibromyalgia, for concluding that no other condition is causing the pain. Healthcare professionals may rule out other conditions that may have similar symptoms with some tests including complete blood count, Rheumatoid factor, thyroid function tests, anti-nuclear antibody, cyclic citrullinated peptide test etc.
Read more about Fibromyalgia - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/
Report Highlights:
Global Insight Service's, Fibromyalgia - Drug Pipeline Landscape, 2022 report provides an overview of the Fibromyalgia pipeline drugs. This report covers detailed insights on Fibromyalgia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Fibromyalgia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology:
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31036/
Scope:
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Key Players:
- Aardvark Therapeutics Inc
- Aptinyx
- Astellas Pharma Inc
- Cortene Inc
- Shanghai lvdao pharmaceutical technology co., Ltd
- Pfizer
- Tonix Pharmaceuticals, Inc.
- TRYP Therapeutics
Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31036/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibromyalgia - Drug Pipeline Landscape, 2022 here
News-ID: 2697716 • Views: …
More Releases from Global Insight Services
Dna Test Kits Market Is Anticipated To Expand From $2.8 Billion In 2024 To $13.1 …
Market Overview
The DNA Test Kits Market has emerged as one of the most dynamic sectors in the healthcare and consumer wellness industries. These kits allow individuals to gain valuable insights into their ancestry, health predispositions, and lifestyle traits by simply submitting a saliva sample. The convenience of at-home testing, combined with digital platforms for data interpretation, has made genetic information more accessible than ever before. The rising interest in personalized…
Extended Reality Market Is Anticipated To Expand From $48.2 Billion In 2024 To $ …
Market Overview
The Extended Reality Market is rapidly evolving as organizations and consumers alike embrace immersive technologies. Extended reality (XR) is an umbrella term that combines virtual reality (VR), augmented reality (AR), and mixed reality (MR), offering users engaging digital experiences that bridge the physical and virtual worlds. With applications ranging from gaming and entertainment to healthcare, education, and industrial training, XR has become a catalyst for digital transformation. The growing…
Building Information Modeling Market to Surpass $35.2 Bn by 2034 at 9% CAGR
Market Overview
Building Information Modeling Market is undergoing rapid transformation as digital construction technologies redefine the way projects are designed, built, and managed. BIM offers a comprehensive digital representation of physical and functional characteristics of buildings, enabling architects, engineers, and contractors to collaborate more effectively. This collaborative approach minimizes costly errors, enhances resource optimization, and improves overall project efficiency. Governments and private firms alike are recognizing BIM as an essential tool…
Connected Healthcare Market to Reach $297.5 Bn by 2034, Growing at 13.3% CAGR
Market Overview
Connected Healthcare Market is rapidly transforming the way medical services are delivered, managed, and experienced. By integrating technologies such as telemedicine, wearable devices, mobile health apps, and cloud-based platforms, connected healthcare empowers patients and providers with seamless communication and real-time data access. This digital shift is not only improving patient outcomes but also reducing the strain on traditional healthcare systems. With a strong emphasis on efficiency, personalization, and accessibility,…
More Releases for Fibromyalgia
Government Initiatives On Musculoskeletal Health Propel Growth In The Fibromyalg …
The Fibromyalgia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Fibromyalgia Treatment Market?
The market for the treatment of fibromyalgia has been expanding consistently in past years. At a compound annual growth rate (CAGR) of 3.9%, it is…
SN Clinic's Effective Treatment of Fibromyalgia Symptoms
Image: https://www.globalnewslines.com/uploads/2025/02/1740408683.jpg
SN Clinic Logo
Fibromyalgia can be a debilitating condition, but SN Clinic offers hope through innovative treatments like MLS Laser Therapy and complementary massage therapies. By addressing chronic pain through a holistic approach, patients can experience significant relief and an improved quality of life.
What is Fibromyalgia and What Does Current Data Say?
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Affecting…
Prominent Fibromyalgia Treatment Market Trend for 2025: Market Leaders Focus On …
What Are the Projected Growth and Market Size Trends for the Fibromyalgia Treatment Market?
The Fibromyalgia Treatment market is expected to grow from $2.79 billion in 2024 to $2.9 billion in 2025, at a CAGR of 3.9%. This growth is attributed to the increasing prevalence of fibromyalgia, greater awareness about the condition, government initiatives, and rising disposable incomes.
The fibromyalgia treatment market is projected to see steady growth, reaching $3.45 billion by…
Advancements in Fibromyalgia Treatments Driving Market Expansion
The fibromyalgia treatment market is experiencing a steady upward trajectory, with significant growth expected over the next decade. Estimated at USD 2.77 billion in 2023, the market is projected to reach approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032. This expansion is driven by several key factors, including advances in treatment options, increasing demand for effective therapies, and…
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues.
Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD.
To know more about Fibromyalgia - Drug Pipeline, visit - https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/
Fibromyalgia…
Fibromyalgia Treatment Market 2022 | Increased Morbidity of Fibromyalgia Along w …
According to Precision Business Insights (PBI), the latest report, the Fibromyalgia Treatment market is expected to be valued at USD 3,017.9 million in 2022, growing at an 3.8% CAGR from 2022 to 2028. Fibromyalgia treatment market analysis projects that the increased prevalence of fibromyalgia and its related complication compelled the introduction of targeted & precise treatment methods for fibromyalgia. Also, the increase in awareness about fibromyalgia will give the required…
